Giovanni Cammarota
Giovanni Cammarota
Internal medicine and Gastroenterology, Catholic University, Rome, Italy
Verified email at
TitleCited byYear
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
L Miele, V Valenza, G La Torre, M Montalto, G Cammarota, R Ricci, ...
Hepatology 49 (6), 1877-1887, 2009
Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study
F Cremonini, S Di Caro, M Covino, A Armuzzi, M Gabrielli, L Santarelli, ...
The American journal of gastroenterology 97 (11), 2744-2749, 2002
Association of Virulent Helicobacter pylori Strains With Ischemic Heart Disease
V Pasceri, G Cammarota, G Patti, L Cuoco, A Gasbarrini, RL Grillo, ...
Circulation 97 (17), 1675-1679, 1998
The effect of oral administration of Lactobacillus GG on antibiotic‐associated gastrointestinal side‐effects during Helicobacter pylori eradication therapy
A Armuzzi, F Cremonini, F Bartolozzi, F Canducci, M Candelli, V Ojetti, ...
Alimentary pharmacology & therapeutics 15 (2), 163-169, 2001
Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review
G Cammarota, G Ianiro, A Gasbarrini
Journal of clinical gastroenterology 48 (8), 693-702, 2014
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection
G Cammarota, L Masucci, G Ianiro, S Bibb˛, G Dinoi, G Costamagna, ...
Alimentary pharmacology & therapeutics 41 (9), 835-843, 2015
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates
F Canducci, A Armuzzi, F Cremonini, G Cammarota, F Bartolozzi, P Pola, ...
Alimentary pharmacology & therapeutics 14 (12), 1625-1629, 2000
European consensus conference on faecal microbiota transplantation in clinical practice
G Cammarota, G Ianiro, H Tilg, M Rajilić-Stojanović, P Kump, R Satokari, ...
Gut 66 (4), 569-580, 2017
Management and treatment of lactose malabsorption
M Montalto, V Curigliano, L Santoro, M Vastola, G Cammarota, R Manna, ...
World journal of gastroenterology: WJG 12 (2), 187, 2006
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study
A Armuzzi, F Cremonini, V Ojetti, F Bartolozzi, F Canducci, M Candelli, ...
Digestion 63 (1), 1-7, 2001
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth
G Nucera, M Gabrielli, A Lupascu, EC Lauritano, A Santoliquido, ...
Alimentary pharmacology & therapeutics 21 (11), 1391-1395, 2005
Efficacy of two one‐week rabeprazole/levofloxacin‐based triple therapies for Helicobacter pylori infection
G Cammarota, R Cianci, O Cannizzaro, L Cuoco, G Pirozzi, A Gasbarrini, ...
Alimentary pharmacology & therapeutics 14 (10), 1339-1343, 2000
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in irritable bowel syndrome
A Lupascu, M Gabrielli, EC Lauritano, E Scarpellini, A Santoliquido, ...
Alimentary pharmacology & therapeutics 22 (11‐12), 1157-1160, 2005
Dose–response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial
G Addolorato, L Leggio, A Ferrulli, S Cardone, G Bedogni, F Caputo, ...
Alcohol and Alcoholism 46 (3), 312-317, 2011
Bacillus clausii therapy to reduce side‐effects of anti‐Helicobacter pylori treatment: randomized, double‐blind, placebo controlled trial
EC Nista, M Candelli, F Cremonini, IA Cazzato, MA Zocco, F Franceschi, ...
Alimentary pharmacology & therapeutics 20 (10), 1181-1188, 2004
An insight into the diagnosis and pathogenesis of hepatitis C virus infection
M Irshad, DS Mankotia, K Irshad
World journal of gastroenterology: WJG 19 (44), 7896, 2013
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility
F Scaldaferri, V Gerardi, LR Lopetuso, F Del Zompo, F Mangiola, ...
BioMed research international 2013, 2013
Levofloxacin‐based triple therapy vs. quadruple therapy in second‐line Helicobacter pylori treatment: a randomized trial
EC Nista, M Candelli, F Cremonini, IA Cazzato, S Di Caro, M Gabrielli, ...
Alimentary pharmacology & therapeutics 18 (6), 627-633, 2003
Onset of coeliac disease during treatment with interferon for chronic hepatitis C
G Cammarota, L Cuoco, R Cianci, F Pandolfi, G Gasbarrini
The Lancet 356 (9240), 1494-1495, 2000
Rifaximin dose‐finding study for the treatment of small intestinal bacterial overgrowth
EC Lauritano, M Gabrielli, A Lupascu, A Santoliquido, G Nucera, ...
Alimentary pharmacology & therapeutics 22 (1), 31-35, 2005
The system can't perform the operation now. Try again later.
Articles 1–20